Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny Shannon

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|May 3, 2006
Traffic fineJenny Shannon
Australian Family Physician|February 2, 2008
Beyond chemotherapy--demystifying the new 'targeted' cancer treatmentsRachel Dear, Nicholas Wilcken, Jenny Shannon
Clinical Colorectal Cancer|May 14, 2016
Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysisDhanusha Sabanathan, Guy D Eslick, Jenny Shannon
PLOS Global Public Health|August 20, 2025
Turning challenges into opportunities: Lessons from Ethiopia's COVID-19 response for strengthening health systems and health securityMuluneh Yigzaw Mossie, Jenny Shannon, Amare Bayeh Desta, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2010
Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomasDavid Goldstein, M Corona Gainford, Chris Brown, et al.
BMC Cancer|August 1, 2015
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trialAlexander Stein, Dirk Arnold, John Bridgewater, et al.
JAMA|May 4, 2016
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical TrialPascal Hammel, Florence Huguet, Jean-Luc van Laethem, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 18, 2017
Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaAndrew J Martin, Emma Gibbs, Katrin Sjoquist, et al.
BMC Cancer|April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trialsMairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.
Journal of Hepatology|May 25, 2020
Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancerMairéad Geraldine McNamara, Andre Lopes, Harpreet Wasan, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|May 3, 2006
Traffic fineJenny Shannon
Australian Family Physician|February 2, 2008
Beyond chemotherapy--demystifying the new 'targeted' cancer treatmentsRachel Dear, Nicholas Wilcken, Jenny Shannon
Clinical Colorectal Cancer|May 14, 2016
Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysisDhanusha Sabanathan, Guy D Eslick, Jenny Shannon
PLOS Global Public Health|August 20, 2025
Turning challenges into opportunities: Lessons from Ethiopia's COVID-19 response for strengthening health systems and health securityMuluneh Yigzaw Mossie, Jenny Shannon, Amare Bayeh Desta, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2010
Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomasDavid Goldstein, M Corona Gainford, Chris Brown, et al.
BMC Cancer|August 1, 2015
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trialAlexander Stein, Dirk Arnold, John Bridgewater, et al.
JAMA|May 4, 2016
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical TrialPascal Hammel, Florence Huguet, Jean-Luc van Laethem, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 18, 2017
Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaAndrew J Martin, Emma Gibbs, Katrin Sjoquist, et al.
BMC Cancer|April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trialsMairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.
Journal of Hepatology|May 25, 2020
Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancerMairéad Geraldine McNamara, Andre Lopes, Harpreet Wasan, et al.
Pageof 2